C12Y 304/22032
Stem bromelain
Official title: Stem bromelain (3.4.22.32)
C12Y304/22032 (Stem bromelain) appears on 34 US grants and 59 published applications in this corpus.
Search patents in C12Y- Granted patents
- 34
- Published applications
- 59
- Assignees
- 35
- Inventors
- 89
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 3 |
| 2016 | 1 | 4 |
| 2017 | 4 | 8 |
| 2018 | 2 | 5 |
| 2019 | 4 | 7 |
| 2020 | 5 | 3 |
| 2021 | 3 | 5 |
| 2022 | 4 | 2 |
| 2023 | 3 | 6 |
| 2024 | 1 | 6 |
| 2025 | 1 | 2 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bromelain protease, bromelain, jacalin-like lectin, extract from the stem and/or the fruit of a pineapple plant, combination preparation, bromelain protease inhibitor, protein/protease mix, and glycated bromelain protein formed by exogenous non-enzymatic glycation, for use in the treatment or prophylaxis of virus infections caused by coronaviruses in a human or animal15 Sep 2026US 12,734,223 B2Helmholtz-Institut FüR Pharmazeutische Forschung Saarland
- Method for treating and/or improving inflammatory intestinal disease10 Mar 2026US 12,569,545 B2Tunghai University
- Protein hydrolysate composition that increases coalbed methane production23 Sep 2025US 12,421,440 B2
- Implantable device for sustained release of a macromolecular drug compound1 Oct 2024US 12,108,225 B2Celanese EVA Performance Polymers LLC
- Implantable device for sustained release of a macromolecular drug compound4 Jul 2023US 11,690,806 B2Celanese EVA Performance Polymers LLC
- Enhancement and stabilisation of proteolytic activity of proteases6 Aug 2026US 2026/0226451 A1Phoenix Eagle Company Pty. Ltd.
- Compositions and methods for treating fungal infections23 Jul 2026US 2026/0207720 A1Mucpharm Pty Ltd
- Implantable Device for Sustained Release of a Macromolecular Drug Compound26 Feb 2026US 2026/0059238 A1Celanese EVA Performance Polymers LLC
- Compositions for breakdown of gluten proteins28 Aug 2025US 2025/0268995 A1
- Topical Formulations for Reducing Bruising and/or Pain21 Aug 2025US 2025/0262285 A1
Most cited
By later US patents
- Method of enzymatic debridement11US 4,361,551 ARiker Laboratories, Inc. · 1982
- Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome10US 7,794,709 B2MediWound Ltd. · 2010
- Enzymatic debridement therapy for abnormal cell proliferation7US 8,754,045 B22014
- Pet food supplement5US 9,585,925 B1Vetnique Labs LLC · 2017
- Radioprotection, radiomitigation and radiorecovery3US 10,946,075 B12021